Latest Insights & Developments

Discover how Vamstar automates mid-tier RFQ triage, reducing manual effort and boosting win rates. The RFQ Fasttrack Engine helps Pharma and MedTech teams reclaim lost margins through automated processing, SKU mapping, and profitability checks.

Unlock the full potential of IT in Pharma, MedTech, and Biotech commercialisation with AI-driven solutions. While much of life sciences tech focuses on drug development and compliance, a critical gap remains in go-to-market strategies, market access, and commercial execution. Legacy IT systems, fragmented data, and regulatory complexities slow down growth, but AI-powered automation is changing the game. Discover how Vamstar’s Polaris AI streamlines commercialisation by integrating market intelligence, pricing optimisation, and regulatory compliance tracking—driving faster, smarter decisions across 100+ markets. Read more to stay ahead in the evolving life sciences landscape.

For most of the past decade, the working assumption in medical technology was straightforward: grow the top line, and the margins would follow. That assumption is now under strain. A convergence of tariffs, procurement reform, and hospital budget pressure has put MedTech margins under structural pressure that revenue growth alone cannot relieve. The winners won't be the companies that cut hardest—they'll be the ones that learn to compete more deliberately.

AI in tendering isn’t a chat problem—it’s a workflow problem. Discover why Vamstar’s Polaris-powered Tender AI outperforms chatbots with structured, end-to-end decision intelligence for healthcare procurement.

From escalation clauses to renewal windows and pricing triggers, MedTech contracts contain critical commercial value. Discover how Polaris AI helps organisations surface hidden opportunities, reduce response times, and turn contractual intelligence into a competitive advantage in 2026 and beyond.

AI is revolutionizing MedTech and Pharma. Discover 50 AI use cases for tender management, pricing and contract optimisation, market access, market intelligence, sales and account management, commercial operations and data management.

Ahead of The MedTech Forum 2026 in Stockholm, Vamstar explores why the next phase of MedTech growth will depend not only on innovation, but on the ability to execute across tenders, pricing, market access, contracts and evidence management.